| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond this, the company is actively developing a SARS-CoV-2 Biosensor, intended to serve as a supplementary diagnostic tool to existing RNA virus detection …
Over the last 12 months, insiders at Intelligent Bio Solutions Inc. have bought $0 and sold $0 worth of Intelligent Bio Solutions Inc. stock.
On average, over the past 5 years, insiders at Intelligent Bio Solutions Inc. have bought $67,284 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 112,727 shares for transaction amount of $62,000 was made by Sakiris Spiro Kevin (Chief Financial Officer) on 2023‑10‑04.
| 2023-10-04 | Sakiris Spiro Kevin | Chief Financial Officer | 112,727 6.9688% | $0.55 | $62,000 | -47.60% | ||
| 2023-10-04 | TOWERS CHRISTOPHER | director | 9,090 0.5619% | $0.55 | $5,000 | -47.60% | ||
| 2023-09-01 | Simeonidis Harry | CEO | 50 0.0104% | $1.85 | $93 | -84.75% | ||
| 2023-08-31 | Simeonidis Harry | CEO | 100 0.0216% | $1.92 | $192 | -84.66% |
| Sakiris Spiro Kevin | Chief Financial Officer | 117427 3.5404% | $207,845.79 | 1 | 0 | <0.0001% |
| TOWERS CHRISTOPHER | director | 9880 0.2979% | $17,487.60 | 1 | 0 | <0.0001% |
| Simeonidis Harry | CEO | 4180 0.126% | $7,398.60 | 2 | 0 |
$9,837,727 | 35 | 7.68% | $94.71M | |
$58,749,198 | 24 | 16.21% | $100.45M | |
$842,771 | 15 | 6.44% | $214.28M | |
$40,874 | 11 | -4.45% | $1.13M | |
$12,784,886 | 11 | -13.56% | $51.24M |
| Increased Positions | 4 | +20% | 5,342 | +3.95% |
| Decreased Positions | 9 | -45% | 135,023 | -99.77% |
| New Positions | 3 | New | 5,339 | New |
| Sold Out Positions | 8 | Sold Out | 134,164 | Sold Out |
| Total Postitions | 15 | -25% | 5,659 | -95.82% |
| Alyeska Investment Group, L.P. | $531.00 | 6.74% | 67,349 | +5,960 | +9.71% | 2025-09-30 |
| Adar1 Capital Management, Llc | $336.00 | 4.26% | 42,643 | +42,643 | New | 2025-09-30 |
| Vanguard Group Inc | $77.00 | 0.98% | 9,769 | +8,220 | +530.66% | 2025-09-30 |
| Geode Capital Management, Llc | $46.00 | 0.59% | 5,887 | +742 | +14.42% | 2025-09-30 |
| Warberg Asset Management Llc | $35.00 | 0.45% | 4,469 | +4,469 | New | 2025-09-30 |
| Lpl Financial Llc | $20.00 | 0.25% | 2,500 | +2,500 | New | 2025-09-30 |
| Goldman Sachs Group Inc | $10.00 | 0.13% | 1,283 | 0 | 0% | 2025-09-30 |
| Citigroup Inc | $7.00 | 0.09% | 935 | +935 | New | 2025-09-30 |
| Nbc Securities, Inc. | $2.00 | 0.03% | 264 | +29 | +12.34% | 2025-09-30 |
| Curio Wealth, Llc | $2.00 | 0.02% | 200 | +200 | New | 2025-09-30 |